Progress and obstacles in vaccine development for the ehrlichioses

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Ehrlichia are tick-borne obligately intracellular bacteria that cause significant diseases in veterinary natural hosts, including livestock and companion animals, and are now considered important zoonotic pathogens in humans. Vaccines are needed for these veterinary and zoonotic human pathogens, but many obstacles exist that have impeded their development. These obstacles include understanding genetic and antigenic variability, influence of the host on the pathogen phenotype and immunogenicity, identification of the ehrlichial antigens that stimulate protective immunity and those that elicit immunopathology, development of animal models that faithfully reflect the immune responses of the hosts and understanding molecular host-pathogen interactions involved in immune evasion or that may be blocked by the host immune response. We review the obstacles and progress in addressing barriers associated with vaccine development to protect livestock, companion animals and humans against these host defense-evasive and cell function-manipulative, vector-transmitted pathogens.

Original languageEnglish (US)
Pages (from-to)1071-1082
Number of pages12
JournalExpert Review of Vaccines
Volume9
Issue number9
DOIs
StatePublished - Sep 2010

Fingerprint

Ehrlichiosis
Vaccines
Pets
Zoonoses
Livestock
Ehrlichia
Immune Evasion
Host-Pathogen Interactions
Antigenic Variation
Ticks
Immunity
Animal Models
Bacteria
Phenotype
Antigens

Keywords

  • antibody epitope
  • antigenic variation
  • Ehrlichia
  • immune evasion
  • immunopathology
  • immunoprotection
  • tick
  • vaccine
  • zoonosis

ASJC Scopus subject areas

  • Immunology
  • Drug Discovery
  • Pharmacology
  • Molecular Medicine

Cite this

Progress and obstacles in vaccine development for the ehrlichioses. / McBride, Jere; Walker, David.

In: Expert Review of Vaccines, Vol. 9, No. 9, 09.2010, p. 1071-1082.

Research output: Contribution to journalArticle

@article{e7c7bf1fc3194a47affb2a7414c56d4e,
title = "Progress and obstacles in vaccine development for the ehrlichioses",
abstract = "Ehrlichia are tick-borne obligately intracellular bacteria that cause significant diseases in veterinary natural hosts, including livestock and companion animals, and are now considered important zoonotic pathogens in humans. Vaccines are needed for these veterinary and zoonotic human pathogens, but many obstacles exist that have impeded their development. These obstacles include understanding genetic and antigenic variability, influence of the host on the pathogen phenotype and immunogenicity, identification of the ehrlichial antigens that stimulate protective immunity and those that elicit immunopathology, development of animal models that faithfully reflect the immune responses of the hosts and understanding molecular host-pathogen interactions involved in immune evasion or that may be blocked by the host immune response. We review the obstacles and progress in addressing barriers associated with vaccine development to protect livestock, companion animals and humans against these host defense-evasive and cell function-manipulative, vector-transmitted pathogens.",
keywords = "antibody epitope, antigenic variation, Ehrlichia, immune evasion, immunopathology, immunoprotection, tick, vaccine, zoonosis",
author = "Jere McBride and David Walker",
year = "2010",
month = "9",
doi = "10.1586/erv.10.93",
language = "English (US)",
volume = "9",
pages = "1071--1082",
journal = "Expert Review of Vaccines",
issn = "1476-0584",
publisher = "Expert Reviews Ltd.",
number = "9",

}

TY - JOUR

T1 - Progress and obstacles in vaccine development for the ehrlichioses

AU - McBride, Jere

AU - Walker, David

PY - 2010/9

Y1 - 2010/9

N2 - Ehrlichia are tick-borne obligately intracellular bacteria that cause significant diseases in veterinary natural hosts, including livestock and companion animals, and are now considered important zoonotic pathogens in humans. Vaccines are needed for these veterinary and zoonotic human pathogens, but many obstacles exist that have impeded their development. These obstacles include understanding genetic and antigenic variability, influence of the host on the pathogen phenotype and immunogenicity, identification of the ehrlichial antigens that stimulate protective immunity and those that elicit immunopathology, development of animal models that faithfully reflect the immune responses of the hosts and understanding molecular host-pathogen interactions involved in immune evasion or that may be blocked by the host immune response. We review the obstacles and progress in addressing barriers associated with vaccine development to protect livestock, companion animals and humans against these host defense-evasive and cell function-manipulative, vector-transmitted pathogens.

AB - Ehrlichia are tick-borne obligately intracellular bacteria that cause significant diseases in veterinary natural hosts, including livestock and companion animals, and are now considered important zoonotic pathogens in humans. Vaccines are needed for these veterinary and zoonotic human pathogens, but many obstacles exist that have impeded their development. These obstacles include understanding genetic and antigenic variability, influence of the host on the pathogen phenotype and immunogenicity, identification of the ehrlichial antigens that stimulate protective immunity and those that elicit immunopathology, development of animal models that faithfully reflect the immune responses of the hosts and understanding molecular host-pathogen interactions involved in immune evasion or that may be blocked by the host immune response. We review the obstacles and progress in addressing barriers associated with vaccine development to protect livestock, companion animals and humans against these host defense-evasive and cell function-manipulative, vector-transmitted pathogens.

KW - antibody epitope

KW - antigenic variation

KW - Ehrlichia

KW - immune evasion

KW - immunopathology

KW - immunoprotection

KW - tick

KW - vaccine

KW - zoonosis

UR - http://www.scopus.com/inward/record.url?scp=77956467347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956467347&partnerID=8YFLogxK

U2 - 10.1586/erv.10.93

DO - 10.1586/erv.10.93

M3 - Article

C2 - 20822349

AN - SCOPUS:77956467347

VL - 9

SP - 1071

EP - 1082

JO - Expert Review of Vaccines

JF - Expert Review of Vaccines

SN - 1476-0584

IS - 9

ER -